ALT Stock Summary and Trading Ideas (Altimmune | NASDAQ:ALT)

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

What symbol and exchange does Altimmune shares trade?

Altimmune trades on the NASDAQ stock market under the symbol ALT.

What is Altimmune stock price doing today?

As of February 13, 2026, ALT stock price declined to $4.53 with 3,816,293 million shares trading.

What is Altimmune's Beta?

ALT has a beta of 0.78, meaning it tends to be less sensitive to market movements. ALT has a correlation of 0.02 to the broad based SPY ETF.

How much is Altimmune worth?

ALT has a market cap of $567.30 million. This is considered a Small Cap stock.

How much money does Altimmune make?

Last quarter Altimmune reported $5,000 in Revenue and -$.21 earnings per share. This beat revenue expectation by $4,440 and exceeded earnings estimates by $.07.

What is the highest and lowest price Altimmune traded in the last 3 year period?

In the last 3 years, ALT traded as high as $14.84 and as low as $2.09.

What are the top ETFs holding Altimmune?

The top ETF exchange traded funds that ALT belongs to (by Net Assets): XBI, VTI, IWM, VXF, IBB.

Is Altimmune (ALT) a good investment?

ALT has underperformed the market in the last year with a price return of -27.3% while the SPY ETF gained +13.0%. However, in the short term, ALT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +11.6% vs +1.7% return in SPY. But in the last 2 weeks, ALT shares have been beat by the market, returning -19.1% compared to an SPY return of -1.5%.

What are the support and resistance levels for Altimmune (ALT)?

ALT support price is $4.27 and resistance is $4.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALT shares will trade within this expected range on the day.